Lightweight Aggregate as Internal Curing Agent to Limit Concrete Skrinkage

View/ Open
Issue Date
2011Author
Browning, JoAnn
Darwin, David
Reynolds, Diane
Pendergrass, Benjamin
Publisher
American Concrete Institute
Type
Article
Article Version
Scholarly/refereed, publisher version
Published Version
https://www.concrete.org/publications/internationalconcreteabstractsportal.aspx?m=details&ID=51683467Metadata
Show full item recordAbstract
The effectiveness of prewetted, vacuum saturated (PVS) lightweight aggregate (LWA) as an internal curing agent to reduce concrete shrinkage is evaluated for curing periods of 7 and 14 days. Normalweight aggregate is replaced by LWA at volume replacement levels ranging from 8.9 to 13.8%. Some mixtures contain a partial replacement of portland cement with slag cement while maintaining the paste content at approximately 24.1% of concrete volume. Comparisons are made with mixtures containing low-absorption granite and high-absorption limestone normalweight coarse aggregates. At the replacement levels used in this study, PVS LWA results in a small reduction in concrete density, no appreciable effect on concrete compressive strength, and a substantial decrease in concrete shrinkage for drying periods up to 365 days. Increasing the curing period from 7 to 14 days reduces concrete shrinkage. Thirty and 60% volume replacements of portland cement by slag cement result in reduced shrinkage when used with a porous LWA or normalweight aggregate. After 30 and 365 days of drying, all mixtures with LWA exhibited less shrinkage than the mixtures with either low- or high-absorption normalweight aggregates.
Collections
Citation
Browning, J., Darwin, D., Reynolds, D., and Pendergrass, B., “Lightweight Aggregate as Internal Curing Agent to Limit Concrete Shrinkage,” ACI Materials Journal, Vol. 108, No. 6, Nov.-Dec. 2011, pp. 638-644.
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.